Cite
HARVARD Citation
Piciocchi, A. et al. (2021). Prognostic impact of KMT2A‐AFF1‐positivity in 926 BCR‐ABL1‐negative B‐lineage acute lymphoblastic leukemia patients treated in GIMEMA clinical trials since 1996. American journal of hematology. 96 (9), pp. E334-E338. [Online].